Acute heart failure: management according to the latest ESC guidelines

2016-11-08

Piotr Ponikowski

This lecture was recorded at the 2nd McMaster International Review Course in Internal Medicine in Kraków, Poland. To learn more, visit www.mircim.eu.

0:00

Loaded: 0%

Progress: 0%

Stream TypeLIVE

0:00

See also

Diagnosing non-ST-segment elevation ACS in 2016 How was non-ST-segment elevation acute coronary syndrome diagnosed in 2016?
Quitting smoking, weight gain, and risk of CV events Smoking cessation often causes weight gain that is difficult to manage. Bearing in mind the risk of cardiovascular events, is it better for a patient to continue smoking or to put on weight?
Managing NSTE acute coronary syndromes in 2016 A lecture by Prof. Sanjit Jolly, from McMaster University, Canada, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2016.
How to prevent a cardiovascular event A lecture by Prof. Salim Yusuf, from McMaster University, Canada, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2016.
Heart failure: Diagnosis of rare causes Which patients with heart failure should undergo a thorough diagnosis of rare causes of heart failure such as myopathy or storage diseases?
Invasive treatment in STEMI: PCI of the culprit vessel vs a multivessel approach Which invasive treatment strategy is preferred in ST-segment elevation myocardial infarction (STEMI): PCI of the infarct-related artery only or revascularization of all significant lesions?
Thrombectomy in patients with STEMI undergoing PCI In which patients with ST-segment elevation myocardial infarction (STEMI) treated with percutaneous coronary intervention (PCI) should we perform thrombectomy?
Diuretic treatment in heart failure How to plan diuretic treatment in patients with heart failure to prevent volume overload? Should the treatment be based on the presence of edema or other symptoms or on B-type natriuretic peptide (BNP) levels?
RBBB as an indication for coronary angiography In 2017 ESC guidelines on STEMI management, the presence of RBBB, similarly to LBBB, is now an indication for urgent coronary angiography in patients with symptoms of myocardial ischemia. What is this based on? Should every patient with features of MI and RBBB in ECG undergo urgent coronary angiography? Does it apply only to patients with a new block or also to those with a preexisting block?
Optimal treatment of heart failure in preserved, reduced, or mid-range LVEF What is the optimal treatment of heart failure in patients with preserved, reduced, or mid-range LVEF? Should patients with mid-range LVEF be treated similarly to those with reduced LVEF?

Acute heart failure: management according to the latest ESC guidelines

Social Media